Clinical application of mineralocorticoid receptor antagonists in chronic heart failure

The review of literature discusses pathogenetic aspects of chronic heart failure and post-infarction remodelling in the heart. The focus is on the role of neurohormonal activation and the important role of aldosterone. There is data on the efficacy and safety of drugs belonging to mineralocorticoid...

Full description

Bibliographic Details
Main Author: MG Bubnova
Format: Article
Language:Russian
Published: Remedium Group LLC 2014-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/691
id doaj-03b2820fe788499d91b086eadcddfc0f
record_format Article
spelling doaj-03b2820fe788499d91b086eadcddfc0f2021-07-28T13:29:15ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902014-12-01012708010.21518/2079-701X-2014-12-70-80691Clinical application of mineralocorticoid receptor antagonists in chronic heart failureMG Bubnova0National Research Center for Preventive Medicine, MoscowThe review of literature discusses pathogenetic aspects of chronic heart failure and post-infarction remodelling in the heart. The focus is on the role of neurohormonal activation and the important role of aldosterone. There is data on the efficacy and safety of drugs belonging to mineralocorticoid receptor antagonists obtained in the course of randomized clinical trials. Different aspects of clinical application of the selective aldosterone receptor blocker eplerenone are emphasized. The application in clinical practice is supported by research findings.https://www.med-sovet.pro/jour/article/view/691хроническая сердечная недостаточностьинфаркт миокардаальдостеронантагонисты минералокортикоидных рецепторовэплеренонchronic heart failuremyocardial infarctionaldosteronemineralocorticoid receptor antagonistseplerenone
collection DOAJ
language Russian
format Article
sources DOAJ
author MG Bubnova
spellingShingle MG Bubnova
Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
Медицинский совет
хроническая сердечная недостаточность
инфаркт миокарда
альдостерон
антагонисты минералокортикоидных рецепторов
эплеренон
chronic heart failure
myocardial infarction
aldosterone
mineralocorticoid receptor antagonists
eplerenone
author_facet MG Bubnova
author_sort MG Bubnova
title Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
title_short Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
title_full Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
title_fullStr Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
title_full_unstemmed Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
title_sort clinical application of mineralocorticoid receptor antagonists in chronic heart failure
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2014-12-01
description The review of literature discusses pathogenetic aspects of chronic heart failure and post-infarction remodelling in the heart. The focus is on the role of neurohormonal activation and the important role of aldosterone. There is data on the efficacy and safety of drugs belonging to mineralocorticoid receptor antagonists obtained in the course of randomized clinical trials. Different aspects of clinical application of the selective aldosterone receptor blocker eplerenone are emphasized. The application in clinical practice is supported by research findings.
topic хроническая сердечная недостаточность
инфаркт миокарда
альдостерон
антагонисты минералокортикоидных рецепторов
эплеренон
chronic heart failure
myocardial infarction
aldosterone
mineralocorticoid receptor antagonists
eplerenone
url https://www.med-sovet.pro/jour/article/view/691
work_keys_str_mv AT mgbubnova clinicalapplicationofmineralocorticoidreceptorantagonistsinchronicheartfailure
_version_ 1721274701151469568